Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Eastbourne Capital Management Llc/ca
Relationship:   10% Owner
City:   San Rafael
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   44,385,290    

Indirect Shares

  48,092,752      
Direct Value   $1,012,110,890    

Indirect Value

  $559,752,936      
Total Shares   92,478,042      
Total Value   $1,571,863,826      


Cassava Sciences Inc
 $72,162,757 Mabvax Therapeutics Holdings Inc
 $272,550 Amylin Pharmaceuticals Inc
 $0 MGIC Investment Corp
 $210,938,982 Sarepta Therapeutics Inc
 $728,736,600 Cassava Sciences Inc
 $72,162,757 Mabvax Therapeutics Holdings Inc
 $272,550 Amylin Pharmaceuticals Inc
 $0 MGIC Investment Corp
 $210,938,982 Sarepta Therapeutics Inc
 $728,736,600
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cassava Sciences Inc SAVA 10% Owner 2009-09-29 3,230,204 2007-12-31 10,901,174    Premium*  
            Mabvax Therapeutics Holdings Inc MBVX 10% Owner 2009-09-30 11,850,000 2010-05-10 1,532,709    Premium*  
            Amylin Pharmaceuticals Inc AMLN 10% Owner 2009-09-17 13,346,120 2007-12-31 20,220,126    Premium*  
            MGIC Investment Corp MTG 10% Owner 2009-09-16 10,299,755 2009-03-11 15,438,743    Premium*  
            Sarepta Therapeutics Inc SRPT 10% Owner 2010-03-04 5,659,211 0    Premium*  
* Premium Members only  

Records found :    88         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2007-12-31 3 IO $0.00 $0 I/I 0 10,901,174 -
MBVX Mabvax Therapeutics Holdi... 10% Owner   –       –       •   2007-12-31 3 IO $0.00 $0 I/I 0 15,736,019 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2007-12-31 3 IO $0.00 $0 I/I 0 20,220,126 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-14 4 B $9.75 $111,638 D/D 11,450 10,912,624 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-15 4 B $9.63 $82,337 D/D 8,550 10,921,174 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-16 4 B $9.53 $2,621 D/D 275 10,921,449 2.37 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-17 4 B $9.49 $282,594 D/D 29,700 10,951,149 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-22 4 B $8.89 $154,019 D/D 17,325 10,968,474 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-29 4 B $9.03 $183,706 D/D 20,344 10,988,818 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-01-30 4 B $8.95 $331,651 D/D 37,056 11,025,874 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-02-22 4 B $8.98 $89,800 D/D 10,000 11,035,874 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-02-28 4 B $8.89 $222,250 D/D 25,000 11,060,874 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-02-28 4 B $27.40 $685,000 D/D 25,000 20,245,126 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-02-29 4 B $26.45 $1,333,198 D/D 50,000 20,295,126 2.45 -
SAVA Cassava Sciences Inc 10% Owner   –       –       •   2008-02-29 4 B $8.76 $131,400 D/D 15,000 11,075,874 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-03-17 4 B $24.50 $742,742 D/D 30,316 20,325,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-03-25 4 B $28.61 $2,574,900 D/D 90,000 20,415,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-03-26 4 B $28.03 $1,152,661 D/D 41,067 20,456,509 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-03-28 4 B $28.10 $3,342,017 D/D 118,933 20,575,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-03 4 B $30.50 $4,738,918 D/D 155,000 20,730,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-07 4 B $31.52 $1,576,000 D/D 50,000 20,780,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-08 4 B $30.96 $1,548,000 D/D 50,000 20,830,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-09 4 B $30.05 $6,271,435 D/D 208,700 21,039,142 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-11 4 B $29.80 $8,723,362 D/D 291,300 21,330,442 2.45 -
AMLN Amylin Pharmaceuticals In... 10% Owner   –       –       •   2008-04-14 4 B $29.37 $4,336,235 D/D 147,308 21,477,750 2.45 -

  88  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed